SG11201708655UA - A method for predicting the risk of incidence of chronic kidney disease - Google Patents
A method for predicting the risk of incidence of chronic kidney diseaseInfo
- Publication number
- SG11201708655UA SG11201708655UA SG11201708655UA SG11201708655UA SG11201708655UA SG 11201708655U A SG11201708655U A SG 11201708655UA SG 11201708655U A SG11201708655U A SG 11201708655UA SG 11201708655U A SG11201708655U A SG 11201708655UA SG 11201708655U A SG11201708655U A SG 11201708655UA
- Authority
- SG
- Singapore
- Prior art keywords
- predicting
- incidence
- risk
- kidney disease
- chronic kidney
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/665—Assays involving proteins derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
- G01N2333/70—Enkephalins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/34—Genitourinary disorders
- G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15165047 | 2015-04-24 | ||
| PCT/EP2016/058829 WO2016170023A1 (fr) | 2015-04-24 | 2016-04-21 | Méthode permettant de prédire le risque d'incidence d'une maladie rénale chronique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201708655UA true SG11201708655UA (en) | 2017-11-29 |
Family
ID=53015570
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201708655UA SG11201708655UA (en) | 2015-04-24 | 2016-04-21 | A method for predicting the risk of incidence of chronic kidney disease |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US11598781B2 (fr) |
| EP (1) | EP3286570A1 (fr) |
| JP (1) | JP6841765B2 (fr) |
| CN (1) | CN107667294B (fr) |
| CA (1) | CA2983542A1 (fr) |
| HK (1) | HK1250779A1 (fr) |
| RU (1) | RU2733471C2 (fr) |
| SG (1) | SG11201708655UA (fr) |
| WO (1) | WO2016170023A1 (fr) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10849545B2 (en) * | 2016-06-02 | 2020-12-01 | Cardiac Pacemakers, Inc. | Acute kidney injury detection system and methods |
| ES2933988T3 (es) * | 2018-03-23 | 2023-02-15 | Hoffmann La Roche | Procedimientos para el cribado de un sujeto por el riesgo de insuficiencia renal crónica y procedimiento implementado por ordenador |
| EP3769086A1 (fr) * | 2018-03-23 | 2021-01-27 | Roche Diabetes Care GmbH | Procédés de dépistage du risque de néphropathie chronique chez un sujet et procédé mis en oeuvre par ordinateur |
| RU2716452C1 (ru) * | 2018-12-28 | 2020-03-11 | Федеральное государственное бюджетное военное образовательное учреждение высшего образования "Военно-медицинская академия имени С.М. Кирова" Министерства обороны Российской Федерации (ВМедА) | Способ прогнозирования развития дисфункции почек в конце подострого периода инфаркта миокарда у мужчин моложе 60 лет |
| KR20210103208A (ko) | 2020-02-13 | 2021-08-23 | 주식회사 케이티 | 다중 에이전트 제어 방법 및 장치 |
| CN111341407A (zh) * | 2020-02-20 | 2020-06-26 | 常州市第一人民医院 | 医院内急性肾损伤预警系统 |
| WO2023210683A1 (fr) * | 2022-04-26 | 2023-11-02 | 国立研究開発法人国立国際医療研究センター | Méthode d'évaluation du risque de déclin de la fonction rénale |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6818418B1 (en) | 1998-12-10 | 2004-11-16 | Compound Therapeutics, Inc. | Protein scaffolds for antibody mimics and other binding proteins |
| AU2002323501C1 (en) | 2001-08-30 | 2010-04-29 | Biorexis Technology, Inc | Modified transferrin fusion proteins |
| DK1531791T3 (da) | 2002-06-07 | 2010-11-01 | Dyax Corp | Forebyggelse og begrænsning af iskæmi |
| CA2543360A1 (fr) | 2003-10-24 | 2005-05-06 | Joost A. Kolkman | Multimeres et monomeres comprenant des domaines de recepteur de lipoproteines de basse densite de classe a et egf |
| US20100028995A1 (en) | 2004-02-23 | 2010-02-04 | Anaphore, Inc. | Tetranectin Trimerizing Polypeptides |
| DE602005026931D1 (de) * | 2004-05-13 | 2011-04-28 | Brahms Gmbh | Verwendung von vorstufen von enkephalinen und/oder deren fragmenten in der medizinischen diagnostik |
| WO2006032436A2 (fr) | 2004-09-21 | 2006-03-30 | Nascacell Technologies Ag. | Utilisation de microproteines en tant qu'inhibiteurs d'une tryptase |
| EP2231860B1 (fr) | 2007-12-19 | 2011-10-05 | Affibody AB | Polypeptide dérivé d'une protéine et se liant au pdgf |
| EP2180322A1 (fr) * | 2008-10-22 | 2010-04-28 | BRAHMS Aktiengesellschaft | Biomarqueurs de pronostic pour la progression d'une maladie de reins chroniques primaires |
| WO2010060748A1 (fr) | 2008-11-03 | 2010-06-03 | Molecular Partners Ag | Protéines de liaison inhibant l’interaction du récepteur vegf-a |
| CA2772162C (fr) | 2009-08-27 | 2018-05-22 | Covagen Ag | Fynomer anti-il-17a et leurs usages medicaux |
| US20120301393A1 (en) | 2009-12-14 | 2012-11-29 | Scil Proteins Gmbh | Modified ubiquitin proteins having a specific binding activity for the extradomain b of fibronectin |
| CN105949301B (zh) | 2010-06-08 | 2020-03-27 | 皮里斯制药有限公司 | 结合IL-4受体α的泪脂质运载蛋白突变蛋白 |
| EP2601532B1 (fr) * | 2010-08-06 | 2016-01-27 | Mycartis N.V. | Utilisation de perlecan en tant que biomarqueur d'un dysfonctionnement rénal |
| CN102636652A (zh) * | 2012-04-18 | 2012-08-15 | 苏州大学 | 尿液中可溶性Corin在慢性肾病诊断中的应用 |
| CA2886779C (fr) * | 2012-10-02 | 2022-11-01 | Sphingotec Gmbh | Methode permettant de diagnostiquer ou de surveiller la fonction renale ou de diagnostiquer une dysfonction renale |
-
2016
- 2016-04-21 EP EP16721698.5A patent/EP3286570A1/fr active Pending
- 2016-04-21 JP JP2017552141A patent/JP6841765B2/ja active Active
- 2016-04-21 CA CA2983542A patent/CA2983542A1/fr not_active Abandoned
- 2016-04-21 CN CN201680022698.4A patent/CN107667294B/zh active Active
- 2016-04-21 US US15/569,018 patent/US11598781B2/en active Active
- 2016-04-21 RU RU2017134388A patent/RU2733471C2/ru active
- 2016-04-21 WO PCT/EP2016/058829 patent/WO2016170023A1/fr active Application Filing
- 2016-04-21 SG SG11201708655UA patent/SG11201708655UA/en unknown
-
2018
- 2018-08-03 HK HK18110031.0A patent/HK1250779A1/zh unknown
-
2022
- 2022-11-14 US US17/986,255 patent/US20230127440A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP6841765B2 (ja) | 2021-03-10 |
| EP3286570A1 (fr) | 2018-02-28 |
| RU2733471C2 (ru) | 2020-10-01 |
| RU2017134388A (ru) | 2019-04-03 |
| US11598781B2 (en) | 2023-03-07 |
| HK1250779A1 (zh) | 2019-01-11 |
| CN107667294A (zh) | 2018-02-06 |
| CN107667294B (zh) | 2021-12-17 |
| US20230127440A1 (en) | 2023-04-27 |
| WO2016170023A1 (fr) | 2016-10-27 |
| US20180128838A1 (en) | 2018-05-10 |
| CA2983542A1 (fr) | 2016-10-27 |
| RU2017134388A3 (fr) | 2019-10-14 |
| JP2018519499A (ja) | 2018-07-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1250779A1 (zh) | 用於預測慢性腎病發生風險的方法 | |
| GB201621919D0 (en) | Method for detecting wellbore influx | |
| PT3368683T (pt) | Método para a quantificação de pd-l1 | |
| SG11201706686YA (en) | Methods for determining resist deformation | |
| HK1249124A1 (zh) | 用於表位選擇的新方法 | |
| GB201516858D0 (en) | A Fluid System | |
| HK1210671A1 (en) | Method for manufacturing seasoned laver | |
| HK1231556A1 (zh) | 確定組織放射敏感性的預測方法 | |
| HK1244314A1 (zh) | 一種預測受試者的肥胖風險的方法 | |
| DK3262443T3 (en) | Transducer Orientation Determination | |
| HK1250785A1 (zh) | 腎病的病態生物標誌物 | |
| FR3040400B1 (fr) | Procede pour commander un etaleur-nappeur | |
| IL239188A0 (en) | Methods for predicting hepatotoxicity | |
| GB2552271B (en) | A method for diagnosing lung cancer | |
| GB2555743B (en) | Predicting wellbore operation parameters | |
| GB201402036D0 (en) | Method for determination of the status of a disease | |
| DK3324181T3 (en) | Transducer omfattende en indretning til at emittere torsionsultralydbølger | |
| GB2537051B (en) | Pipe cutter | |
| EP3217173A4 (fr) | Procédé de détection de maladies | |
| GB201507402D0 (en) | Pipe Forming Method | |
| GB2531323B (en) | Pipe section | |
| EP3289355A4 (fr) | Procédés de détection d'une maladie rénale | |
| GB201604217D0 (en) | Ultrasound method | |
| ZA201803107B (en) | A surrounding member for a pipe | |
| EP3371592C0 (fr) | Procédé permettant de quantifier des anticorps thérapeutiques |